Papers
Olanzapine
for the treatment of borderline personality disorder: variable dose
12-week randomised double-blind placebo-controlled study S.
Charles Schulz, Mary C. Zanarini, Anthony Bateman, Martin Bohus,
Holland C. Detke, Quynh Trzaskoma, Yoko Tanaka, Daniel Lin, Walter
Deberdt, and Sara Corya ;Br J Psychiatry 2008 193: 485-492
Duration of
antidepressant use during pregnancy and risk of major congenital
malformations
Élodie Ramos, Martin St-André, Évelyne Rey, Driss Oraichi, and
Anick Bérard ;Br J Psychiatry 2008 192: 344-350
Subunit-Selective
Modulation of GABA Type A Receptor Neurotransmission and Cognition
in Schizophrenia David A. Lewis, M.D., Raymond Y. Cho, M.D.,
Cameron S. Carter, M.D., Kevin Eklund, R.N., B.S.N., Sarah Forster,
B.S., Mary Ann Kelly, Ph.D., and Debra Montrose, Ph.D., L.S.W; Am J
Psychiatry 2008; 165:1585-1593
A
UK consensus on the administration of aripiprazole for the
treatment of mania. KJ Aitchison, M Bienroth, J Cookson, R
Gray, PM Haddad, B Moore, L Ratna, G Sullivan, D Taylor, M Taylor,
and GM Goodwin. J Psychopharmacol first published on November 14,
2008 as doi:10.1177/0269881108098820
Interrater
reliability of the Antipsychotic Non-Neurological Side-Effects
Rating Scale measured in patients treated with clozapine.Ohlsen
RI, Williamson R, Yusufi B, Mullan J, Irving D, Mukherjee S, Page
E, Aitchison KJ, Barnes TRE. J Psychopharmacol 2008; 22; 323;
DOI: 10.1177/0269881108091069
Change in
sexual dysfunction on aripiprazole: a switching or add-on
study.Mir A, Shivakumar K, Williamson RJ, McAllister VDM,
O’Keane V, Aitchison KJ. J Psychopharmacol 2008; 22; 244
originally published online Feb 28, 2008; DOI:
10.1177/0269881107082901
Antidepressants for Bipolar depression: A systematic review of
Randomized controlled trials. Gijsman et al, Am J Psychiatry;
161:1537-1547.
Prediction of Antidepressant response to Milnacipran by
Norepinephrine Transporter Gene Polymorphisms. Yoshida et al; Am J
Psychiatry; 161:1575-1580
Preliminary RCT of Pramipexole added to mood stabilisers for
Treatment resistant BPD.
Am J Psych 2004; 161: 564-566
Long Term Lithium therapy for BPD: Systematic Review and
Meta-analysis of RCT's.
Geddes et al, Am. J. Psych 2004; 161:2, 217-222.
Useful : Practice Guideline for the Treatment of Schizophrenia
(2nd ed) Am J Psych Vol 161:2 2004 Supplement
Separation of anxiety and depressive disorders: blind alley in
psychopharmacology and classification of disease
BMJ 2003;327:158-160 (19 July)
Type of antidepressant is not linked to suicide rates
BMJ 2003;327 (12 July)
Meltzer HY et al: Clozapine treatment for suicidality in
schizophrenia.
Archives of General Psychiatry 2003;60:82-91
Assessment of independent effect of Olanzapine and risperidone
on risk of diabetes among patients with schizophrenia
BMJ Aug 2002; 325 p243 [full text of
article]
Antipsychotic drugs and cardiac arrest
BMJ Nov 2002; 325 p1070-1072 [full text of
article]
50 years with Lithium treatment in affective disorders: Present
and priorities
World Journal of Biological Psychiatry (Jan 2001) 2,
18-26
A comparison of risperidone and haloperidol for the prevention
of relapse in patients with schizophrenia.
New England Journal of Medicine 2002; 346(1):16-22 [full text of
article]
|